Paclitaxel (175 mg/m2 over 3 hours) with cisplatin or carboplatin in previously untreated ovarian cancer: An interim analysis

Seminars in Oncology

Volumn 24, Issue 5 SUPPL. 15, 1997, Pages

  Neijt, J P ^a   Engelholm, S A ^a   Witteveen, P O ^a   Tuxen, M K ^a   Sorensen, P G ^a   Hansen, M ^a   Hirsch, F ^a   Sessa, C ^a   De Swart, C ^a   van Houwelingen, H C ^a   Lund, B ^a   Hansen, S W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ADULT; AGED; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; DOSE CALCULATION; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; NEUROTOXICITY; OVARY CANCER; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; VOMITING;

ADULT; AGED; AMBULATORY CARE; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; BONE MARROW; CARBOPLATIN; CARCINOMA; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; MIDDLE AGED; NAUSEA; NERVOUS SYSTEM DISEASES; OVARIAN NEOPLASMS; PACLITAXEL; REMISSION INDUCTION; SURVIVAL RATE; VOMITING;

EID: 0030868372     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)